Japanese Encephalitis Vaccine, Inactivated, Adsorbed (Ixiaro)
Japanese Encephalitis Vaccine, Inactivated, Adsorbed is an FDA-licensed reference biologic from Valneva Austria GmbH. Reference exclusivity, biosimilar lineage, and published patents from official FDA Purple Book records.
0
Biosimilars
0
Interchangeables
0
Listed patents
2009
Reference approved
Reference product
Ixiaro Japanese Encephalitis Vaccine, Inactivated, Adsorbed
Valneva Austria GmbH
- Approved
- Mar 30, 2009
- Marketing
- Rx
- Center
- CBER
- Patents
- None listed
Exclusivity & patent cliffs
Approval, exclusivity, and published-patent expiration dates for Japanese Encephalitis Vaccine, Inactivated, Adsorbed, in chronological order.
Reference approval
Approval date of the reference Japanese Encephalitis Vaccine, Inactivated, Adsorbed product.
17 yr 5 mo ago
Orphan exclusivity ends
7-year orphan-drug exclusivity window.
6 yr 2 mo ago
Frequently asked questions
Are there biosimilars approved for Japanese Encephalitis Vaccine, Inactivated, Adsorbed (Ixiaro)?
No 351(k) biosimilars or interchangeable biosimilars referencing Japanese Encephalitis Vaccine, Inactivated, Adsorbed are listed in the FDA Purple Book yet.
Explore the full FDA Purple Book
Search every FDA-licensed biologic, biosimilar, and interchangeable with exclusivity timelines and patent records.